Market Research Report
European Antibiotics Market by Drug Class, Drug Origin, Spectrum of Activity, and Route of Administration : Opportunity Analysis and Industry Forecast, 2019-2027
|Published by||Allied Market Research||Product code||1000271|
|Published||Content info||181 Pages
Delivery time: 2-3 business days
|European Antibiotics Market by Drug Class, Drug Origin, Spectrum of Activity, and Route of Administration : Opportunity Analysis and Industry Forecast, 2019-2027|
|Published: February 24, 2021||Content info: 181 Pages||
The European antibiotics market was valued at $11,561 million in 2019, and is projected to reach $13,529 million by 2027 at a CAGR of 1.9% from 2020 to 2027.
Antibiotics is an antimicrobial substance or a compound that fights against bacterial infections and sometimes with protozoan infections but not viral infections. Antibiotics are the medications that either stop bacteria from growing or kill bacteria, directly referred as bacteriostatic and bactericidal antibiotics, respectively. There are several types of antibiotics, easily available at the drug store and in the hospital with a prescription or without a prescription in most of the countries. Antibiotics are used during transplants, dialysis, suppressed immune system, joint replacement, and others.
There is an increase in the demand for antibiotics, owing to rise in prevalence of infectious diseases. In addition, development of novel approaches for new antibiotics for treating bacterial infections and a large number of clinical trials further drive the market growth. However, development of antibiotic resistance, driven by misuse of antibiotics and the time taken for the regulatory approval is projected to impede the market growth. On the contrary, discovery of advanced prospect molecules and novel combination therapies to treat antibiotic-resistant microbial infections are expected to offer significant profitable opportunities for the market players.
The European antibiotics market is segmented on the basis of class, drug origin, spectrum of activity, route of administration, and region. By class, the market is classified into beta lactam & beta lactamase inhibitors, quinolones, macrolides, and others. Beta lactam & beta lactamase inhibitors is further segmented into Penicillin, Cephalosporin, Carbapenem, and Monobactam. By drug origin, the market is categorized into natural, semisynthetic, and synthetic. By spectrum of activity, the market is bifurcated into broad-spectrum antibiotic and narrow-spectrum antibiotic. By route of administration, the market is divided into oral, intravenous, and others.
By Drug Class
By Drug Origin
By Spectrum of Activity
By Route of Administration